Profil
Marek Poszepczynski worked as a Licensing Director at Biovitrum AB from 2002 to 2008.
He then worked as a Vice President of Business Development at Karolinska Development AB from 2008 to 2010.
From 2010 to 2012, he was a Lead Equity Analyst at Svenska Handelsbanken AB. He also worked as a Vice President of Business Development at Axelar AB. From 2012 to 2017, he was a Director of Business Development at Calliditas Therapeutics AB. Prior to his business career, he graduated from the Royal Institute of Technology.
Anciens postes connus de Marek Poszepczynski
| Sociétés | Poste | Fin |
|---|---|---|
| CALLIDITAS THERAPEUTICS AB | Corporate Officer/Principal | 01/03/2017 |
| SVENSKA HANDELSBANKEN AB | Corporate Officer/Principal | 01/01/2012 |
| KDVENTURES AB | Corporate Officer/Principal | 01/01/2010 |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and conducts medical research services | Corporate Officer/Principal | 01/01/2008 |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors invests in companies located across the Globe. The firm focuses on biotechnology, pharmaceuticals, medical devices & instruments and healthcare services sectors. It provides financing for seed, early, growth stage and buyout capital requirements. | Private Equity Investor | - |
Formation de Marek Poszepczynski
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors invests in companies located across the Globe. The firm focuses on biotechnology, pharmaceuticals, medical devices & instruments and healthcare services sectors. It provides financing for seed, early, growth stage and buyout capital requirements. | Finance |
Svenska Handelsbanken AB
Svenska Handelsbanken AB Major BanksFinance Provides national commercial banking services | Finance |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and conducts medical research services | Commercial Services |
Svenska Handelsbanken AB (Broker)
Svenska Handelsbanken AB (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Calliditas Therapeutics AB
Calliditas Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Royal Institute of Technology
Royal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Axelar AB
Axelar AB BiotechnologyHealth Technology Provides oral anti-cancer therapies | Health Technology |
Karolinska Development AB
Karolinska Development AB Financial ConglomeratesFinance Operates as a life sciences investment company | Finance |
















